LI, John,LI, Shengwei,LUO, Dixiang,WU, Yiran,ZHOU, Ming,ZHUANG, Xiaolei,HUA, Liang,LUO, Pengyi,WANG, Yang
申请号：
AU2019252262
公开号：
AU2019252262A1
申请日:
2019.04.11
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to a recombinant fusion protein comprising a fragment of the cardioprotective protein neuregulin-1 (NRG-1) fused to a monoclonal antibody (mAb) backbone and to a method of treating a disease or condition in a subject in need thereof comprising administering a therapeutically effective amount of the recombinant fusion protein or the pharmaceutical composition comprising the recombinant fusion protein disclosed herein.
